Skye Bioscience, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Skye Bioscience, Inc. (SKYE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $170.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- Skye Bioscience, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.00.
- Skye Bioscience, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $170.37K.
- Skye Bioscience, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $0.00.
- Skye Bioscience, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $0.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|---|
| 2026-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $170.37K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $170.37K 10-Q · filed 2026-05-11 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |